Literature DB >> 13270336

The influence of rheumatic fever on serum concentrations of the enzyme, glutamic oxalacetic transaminase.

I NYDICK, J TANG, G H STOLLERMAN, F WROBLEWSKI, J S LADUE.   

Abstract

Entities:  

Keywords:  BLOOD; RHEUMATIC FEVER/blood in; TRANSAMINASES

Mesh:

Substances:

Year:  1955        PMID: 13270336     DOI: 10.1161/01.cir.12.5.795

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

1.  Serum glutamic oxalacetic transaminase in acute myocardial infarction.

Authors:  H A DEWAR; N R ROWELL; A J SMITH
Journal:  Br Med J       Date:  1958-11-08

2.  [The behavior of serum glutamic acid-oxalacetic acid transaminase in myopathies and neurogenic muscle atrophies].

Authors:  H E KAESER
Journal:  Dtsch Z Nervenheilkd       Date:  1959

3.  Serum transaminase; a test to aid in diagnosis of cardiac infarction.

Authors:  A DEUTSCH
Journal:  Calif Med       Date:  1956-09

4.  Glutamic Oxaloacetic Transaminase Activity in Serum.

Authors: 
Journal:  Can Med Assoc J       Date:  1956-12-01       Impact factor: 8.262

5.  Serum transaminases and salicylate therapy.

Authors:  T Iancu
Journal:  Br Med J       Date:  1972-04-15

Review 6.  Differences in NSAID tolerability profiles. Fact or fiction?

Authors:  K J Skeith; M Wright; P Davis
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 7.  Enzyme assays in diseases of the heart and skeletal muscle.

Authors:  S B Rosalki
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1970

8.  A clinical and serological comparison of group A versus non-group A streptococcal reactive arthritis and throat culture negative cases of post-streptococcal reactive arthritis.

Authors:  T L Jansen; M Janssen; R Traksel; A J de Jong
Journal:  Ann Rheum Dis       Date:  1999-07       Impact factor: 19.103

Review 9.  Hepatotoxicity of mild analgesics.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.